Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/1999
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999CA2335559A1 Arylsulfonanilide phosphates
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008215 Benzonaphthyridines as bronchial therapeutics
12/28/1999US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin
12/28/1999US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999US6008017 Human cardiac/brain tolloid-like protein
12/28/1999US6007829 Topically applied mixture comprising a carrier and water soluble compound(s) of free acid or salt of ethylene glycol disuccinic acid, 2,2'-oxydisuccinic acid and/or sulfosuccinic acid to increase collagen synthesis in skin cells
12/28/1999US6007827 Method of depigmenting or bleaching mammalian skin using L-2-oxothiazolidine-4-carboxylic acid
12/28/1999CA2099473C Depigmenting cosmetic and/or dermatologic composition containing a di- or tri-cafeoylquinic acid or a blend of these acids
12/28/1999CA2037150C Retinoids
12/28/1999CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065504A1 Extraction method, pharmaceutical composition and a cosmetic composition
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065456A1 Foaming composition for hair care
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999051213A3 The use of polyamines in the treatment of dermatological symptoms
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/22/1999EP0965623A1 Stabilized monomer adhesive compositions
12/22/1999EP0965340A1 Dermatologic preparation
12/22/1999EP0965334A1 Liquid respiratory product for intubation
12/22/1999EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions
12/22/1999EP0965327A1 Wrinkling modifiers
12/22/1999EP0965321A1 Composition for external use
12/22/1999EP0964865A2 Pharmaceutically active tricyclic amines
12/22/1999EP0964864A2 Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/22/1999EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
12/22/1999EP0964681A2 Anticonvulsant derivatives useful in treating psoriasis
12/22/1999EP0964667A2 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
12/22/1999EP0910362A4 Oxa acids and related compounds for treating skin conditions
12/22/1999CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999CN1238944A Process for preparing powdered bath lotion from liquid one of natural plant
12/22/1999CN1238943A Method for controlling sebub distribution on facial skin
12/21/1999US6004993 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/21/1999US6004987 Use of ligands which are specific for RXR receptors
12/21/1999US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004964 Administering amide or sulfonamide derivative; analgesics
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064066A1 Immune tolerance-inducing agents containing hard keratin or keratin-like substance
12/16/1999WO1999064063A2 Collagenase application form
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064029A1 Plant extract
12/16/1999WO1999064026A1 A process of powder for bath from natural plants
12/16/1999WO1999064025A1 Tyrosinase inhibitors from plants
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063982A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063828A1 Broad specificity dna damage endonuclease
12/16/1999WO1999063816A1 Method and composition for the treatment of epidermal irritations and infections
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999DE19825794A1 Collagenase-Applikationsform Collagenase application form
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334335A1 Tyrosinase inhibitors from plants
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 1065